Close X
Tuesday, November 26, 2024
ADVT 
International

H-2B visas open for late second half returning workers for FY 2023

Darpan News Desk IANS, 12 Apr, 2023 05:14 PM
  • H-2B visas open for late second half returning workers for FY 2023

New York, April 12 (IANS) The US will begin accepting petitions for H-2B visa workers for the late second half of fiscal year 2023 under the supplemental cap temporary final rule, the federal agency for immigration services announced.

Under this rule, which was announced in December last year, there are 10,000 visas limited to returning workers regardless of country of nationality, for the late second half of fiscal year 2023, that is May 15 to September 30.

"The 10,000 visas made available under this allocation are limited to returning workers who were issued H-2B visas or held H-2B status in fiscal years 2020, 2021, or 2022," the US Citizenship and Immigration Services (USCIS) said.

These supplemental visas are available only to the US businesses that are suffering irreparable harm or will suffer impending irreparable harm without the ability to employ all the H-2B workers requested in their petition, as attested by the employer on a new attestation form.

On December 15, 2022, the Department of Homeland Security (DHS) and the Department of Labor (DOL) jointly published a temporary final rule increasing the cap on H-2B non-immigrant visas by up to 64,716 additional visas for all of FY 2023.

Of the 64,716 additional visas, 44,716 are available only for returning workers (workers who received an H-2B visa or were otherwise granted H-2B status in one of the last three fiscal years).

The remaining 20,000 visas are set aside for nationals of El Salvador, Guatemala, and Honduras (collectively called Northern Central American countries) and Haiti, who are exempt from the returning worker requirement.

As of April 10, 2023, USCIS has received petitions requesting 11,537 workers under the 20,000 visas set aside for nationals of Haiti, El Salvador, Guatemala, and Honduras.

USCIS is continuing to accept H-2B petitions under this allocation.

This is the first time the Departments have issued a single rule making available H-2B supplemental visas for several allocations throughout the entire fiscal year, including an allocation for the late second half.

The temporary final rule features several provisions to protect both, the US and H-2B workers, from exploitation and abuse.

The H-2B visas are issued for seasonal/temporary jobs which allow employers to hire skilled or unskilled workers to fulfil the shortage of workers in the US.

The employer must obtain a Department of Labor certification before the visa application can be initiated.

MORE International ARTICLES

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot

WHO grants emergency authorization for J&J COVID vaccine

WHO grants emergency authorization for J&J COVID vaccine
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

WHO grants emergency authorization for J&J COVID vaccine

Denmark pauses AstraZeneca vaccine jabs to probe blood clots

Denmark pauses AstraZeneca vaccine jabs to probe blood clots
Denmark's Health Authority said its decision was “based on a precautionary principle” and that one person who developed a blood clot after vaccination had died.

Denmark pauses AstraZeneca vaccine jabs to probe blood clots